Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2014 by Stanford University.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Stanford University Identifier:
First received: March 14, 2012
Last updated: February 19, 2014
Last verified: February 2014
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Cutaneous Lymphoma
Other Skin Disorders
Mycosis Fungoides
Cutaneous T-cell Lymphoma

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Resource links provided by NLM:

Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Number of mutations [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    Identify mutations, changes in DNA copy number, structural rearrangements, or altered coding and non-coding RNA expression

Biospecimen Retention:   Samples With DNA
whole blood tissue

Estimated Enrollment: 30
Study Start Date: June 2011
Estimated Study Completion Date: April 2015
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Eligible subjects will be identified and recruited by referral from that individual's treating physician, mainly Stanford-affiliated dermatologists, oncologists, and hematologists.

Inclusion Criteria:

  • 18 years of age or older
  • Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined.
  • Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

- Less than 18 years of age

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01556828

Contact: Alexander Ungewickell 650-723-6661

United States, California
Stanford University Cancer Institute Recruiting
Stanford, California, United States, 94305
Sub-Investigator: Youn Kim, MD         
Sub-Investigator: Carolyn Lee, MD         
Sub-Investigator: Bruno C Medeiros, MD         
Sub-Investigator: Alexander Ungewickell, MD         
Sponsors and Collaborators
Stanford University
Principal Investigator: Paul Khavari, MD Stanford University
  More Information

Responsible Party: Stanford University Identifier: NCT01556828     History of Changes
Other Study ID Numbers: LYMNHL0091  SU-03142012-9329  21750 
Study First Received: March 14, 2012
Last Updated: February 19, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hematologic Diseases
Skin Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Lymphoma, T-Cell
Lymphoma, T-Cell, Cutaneous
Mycosis Fungoides
Lymphoma, Non-Hodgkin
Neoplasms by Histologic Type processed this record on May 24, 2016